A single center study to evaluate the beta cells function and insulin resistance during tocilizumab treatment in patients with non-diabetic rheumatoid arthritis.
Phase of Trial: Phase II
Latest Information Update: 02 Feb 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Biomarker; Pharmacodynamics
- 02 Feb 2016 New trial record